ZyVersa Therapeutics, Inc. short interest in 2023
In 2023, ZyVersa Therapeutics, Inc.'s disclosed short interest ran from 2.21% of shares outstanding on 31 Mar 2023 to 6.75% on 30 Nov 2023, a change of +4.54 percentage points. The year's high was 12.77% on 14 Jul 2023 and its low 2.02% on 14 Apr 2023, averaging 4.77% across 10 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 7.14 days on 14 Apr 2023. Full history: ZyVersa Therapeutics, Inc..
Cite this page
2023 in figures
- Start of year
- 2.21% (31 Mar 2023)
- End of year
- 6.75% (30 Nov 2023)
- Change
- +4.54 pp
- High
- 12.77% (14 Jul 2023)
- Low
- 2.02% (14 Apr 2023)
- Average
- 4.77%
- Highest days to cover
- 7.14 (14 Apr 2023)
- SEC filings marked
- 6
Every report in 2023
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 31 Mar 2023 | 2.21% | 1.00 | 10-K filed |
| 14 Apr 2023 | 2.02% | 7.14 | results (8-K) |
| 28 Apr 2023 | 2.29% | 1.00 | |
| 15 May 2023 | 2.77% | 1.00 | 10-Q filed, results (8-K) |
| 30 Jun 2023 | 5.17% | 1.00 | |
| 14 Jul 2023 | 12.77% | 1.00 | |
| 31 Jul 2023 | 7.19% | 1.00 | |
| 15 Aug 2023 | 3.42% | 1.00 | |
| 31 Aug 2023 | 3.11% | 1.00 | 10-Q filed |
| 30 Nov 2023 | 6.75% | 1.00 | 10-Q filed |
See also: ZyVersa Therapeutics, Inc.'s full history · most shorted US stocks of 2023 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.